| Literature DB >> 28692652 |
Elvis Genbo Xu1, Edward M Mager2, Martin Grosell3, John D Stieglitz3, E Starr Hazard4,5, Gary Hardiman4,6,7, Daniel Schlenk1.
Abstract
Mahi-mahi (Coryphaena hippurus) is a commercially and ecologically important species of fish occurring in tropical and temperate waters worldwide. Understanding early life events is crucial for predicting effects of environmental stress, which is largely restricted by a lack of genetic resources regarding expression of early developmental genes and regulation of pathways. The need for anchoring developmental stages to transcriptional activities is highlighted by increasing evidence on the impacts of recurrent worldwide oil spills in this sensitive species during early development. By means of high throughput sequencing, we characterized the developmental transcriptome of mahi-mahi at three critical developmental stages, from pharyngula embryonic stage (24 hpf) to 48 hpf yolk-sac larva (transition 1), and to 96 hpf free-swimming larva (transition 2). With comparative analysis by multiple bioinformatic tools, a larger number of significantly altered genes and more diverse gene ontology terms were observed during transition 2 than transition 1. Cellular and tissue development terms were more significantly enriched in transition 1, while metabolism related terms were more enriched in transition 2, indicating a switch progressing from general embryonic development to metabolism during the two transitions. Special focus was given on the most significant common canonical pathways (e.g. calcium signaling, glutamate receptor signaling, cAMP response element-binding protein signaling, cardiac β-adrenergic signaling, etc.) and expression of developmental genes (e.g. collagens, myosin, notch, glutamate metabotropic receptor etc.), which were associated with morphological changes of nervous, muscular, and cardiovascular system. These data will provide an important basis for understanding embryonic development and identifying molecular mechanisms of abnormal development in fish species.Entities:
Mesh:
Year: 2017 PMID: 28692652 PMCID: PMC5503239 DOI: 10.1371/journal.pone.0180454
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1The development of the pharyngula (24 hpf) to yolk sac larva (48 hpf) and the swimming larva (96 hpf).
OFT, outflow tract; PHT, primitive heart tube; A, atria; V, ventricle; F, forebrain; M, midbrain; H, hindbrain.
Statistics of sequencing and mapping to Takifugu rubripes transcriptome (FUGU4).
| Samples (n = 3) | Mean Seqs in FASTQ File | Hits against Fugu protein sequences |
|---|---|---|
| 24 hpf | 49,538,883 | 1,605,640 |
| 48 hpf | 50,136,278 | 1,759,212 |
| 96 hpf | 52,282,330 | 1,776,690 |
| median | 51,466,400 | 1,757,246 |
| Total | 710,845,971 | 24,255,645 |
Fig 2Heatmaps (A and B) showing the Euclidean distances between the samples as calculated from the DEseq2 variance stabilizing transformation of the count data.
Samples are clustered by similarity. The samples from each developmental time point clustered together indicating global differences between the different stages. Plot of normalized mean counts (expression) versus log2 fold change for comparisons in transition 1 (24 hpf versa 48 hpf; C) and transition 2 (48 hpf versa 96 hpf; D). The X-axis plots normalized mean expression and the Y-axis is the log2 fold change (FC). Black dots represent non-significant genes, whereas red dots indicate significant differentially expressed genes (q < 0.05).
Fig 3Developmental stages and numbers of differentially expressed genes (DEGs).
Number of DEGs in the two transitions between the three stages of development, from 24 hpf (pharyngula) to 48 hpf (yolk-sac larva) to 96 hpf (free-swimming larva), with bars representing numbers of total, upregulated and downregulated DEGs. Adjusted p-value < 0.1. The X-axis plots the numbers of DEGs, and the Y-axis represents total, upregulated and downregulated DEGs.
Top enriched molecular functions, components and biological processes.
The shared terms between the two transitions are highlighted in bold. p-value method, hypergeometric probability mass function with FDR correction.
| 1.64E-47 | 621 | 5.64E-40 | 938 | ||
| 4.29E-39 | 776 | 1.40E-33 | 864 | ||
| 3.02E-36 | 764 | 1.90E-33 | 1036 | ||
| 5.85E-27 | 695 | 2.41E-33 | 868 | ||
| 7.17E-27 | 825 | 2.78E-33 | 1027 | ||
| 1.18E-26 | 824 | 4.59E-33 | 1033 | ||
| 1.18E-26 | 818 | 6.83E-32 | 1009 | ||
| 1.23E-26 | 808 | 9.93E-32 | 835 | ||
| 1.23E-26 | 688 | 1.50E-31 | 1004 | ||
| 1.28E-26 | 805 | 2.49E-31 | 1003 | ||
| 1.82E-26 | 803 | 2.50E-31 | 1049 | ||
| 1.82E-26 | 804 | 2.96E-31 | 1001 | ||
| 1.82E-26 | 798 | 8.48E-31 | 993 | ||
| 8.17E-26 | 668 | 5.09E-29 | 683 | ||
| 1.43E-21 | 819 | chromatin binding | 6.16E-26 | 336 | |
| 3.47E-21 | 497 | 2.34E-22 | 873 | ||
| transition metal ion binding | 2.98E-20 | 636 | 4.47E-21 | 602 | |
| zinc ion binding | 3.03E-18 | 535 | phosphotransferase activity, alcohol group acceptor | 1.72E-18 | 452 |
| transferase activity | 1.63E-15 | 451 | gated channel activity | 1.82E-18 | 222 |
| 4.45E-15 | 391 | 1.82E-18 | 487 | ||
| 9.41E-64 | 847 | 1.16E-63 | 959 | ||
| 3.65E-61 | 799 | 3.54E-63 | 1008 | ||
| 9.86E-61 | 744 | 1.05E-60 | 884 | ||
| 2.55E-46 | 591 | 4.20E-44 | 697 | ||
| regulation of nervous system development | 3.62E-46 | 492 | embryo development | 1.01E-42 | 704 |
| 3.47E-45 | 472 | cellular catabolic process | 6.82E-42 | 1045 | |
| neuron projection development | 3.03E-44 | 518 | 2.35E-40 | 545 | |
| 1.12E-43 | 530 | organic substance catabolic process | 1.83E-39 | 1076 | |
| neuron projection morphogenesis | 3.90E-42 | 373 | 6.85E-39 | 992 | |
| 2.60E-41 | 885 | 1.62E-38 | 685 | ||
| regulation of neurogenesis | 1.26E-39 | 435 | positive regulation of RNA metabolic process | 7.37E-38 | 917 |
| regulation of cell differentiation | 3.43E-38 | 800 | positive regulation of nitrogen compound metabolic process | 1.51E-37 | 1085 |
| cell morphogenesis involved in neuron rentiation | 1.05E-37 | 346 | positive regulation of nucleobase-containing compound metabolic process | 1.25E-36 | 1028 |
| central nervous system development | 1.87E-37 | 521 | neuron projection development | 1.25E-36 | 594 |
| regulation of neuron differentiation | 2.01E-37 | 374 | positive regulation of RNA biosynthetic process | 4.21E-36 | 888 |
| 5.65E-36 | 808 | regulation of transcription from RNA polymerase II | 1.57E-35 | 1064 | |
| 3.67E-35 | 563 | positive regulation of transcription, DNA-templated | 6.96E-35 | 875 | |
| head development | 1.30E-33 | 428 | positive regulation of nucleic acid-templated transcription | 6.96E-35 | 875 |
| regulation of anatomical structure | 3.56E-33 | 560 | 9.16E-35 | 1050 | |
| axon development | 7.06E-33 | 302 | 2.28E-34 | 604 | |
| 1.25E-51 | 493 | 1.28E-55 | 586 | ||
| 1.89E-50 | 766 | 5.08E-54 | 927 | ||
| 1.89E-50 | 625 | 4.22E-48 | 736 | ||
| 4.26E-44 | 406 | 7.21E-46 | 733 | ||
| 8.47E-44 | 610 | 1.07E-43 | 474 | ||
| 7.65E-34 | 333 | catalytic complex | 4.32E-42 | 661 | |
| 4.19E-33 | 447 | transferase complex | 2.43E-35 | 463 | |
| 1.93E-28 | 260 | 8.89E-33 | 388 | ||
| 3.41E-28 | 239 | 2.39E-30 | 720 | ||
| cell-substrate adherens junction | 7.60E-28 | 236 | 2.92E-29 | 521 | |
| 1.71E-27 | 233 | plasma membrane region | 2.17E-27 | 601 | |
| 2.49E-27 | 308 | nucleoplasm part | 2.19E-27 | 448 | |
| endoplasmic reticulum | 7.45E-26 | 745 | 8.92E-27 | 362 | |
| adherens junction | 7.08E-25 | 267 | 2.16E-26 | 299 | |
| anchoring junction | 1.94E-24 | 274 | presynapse | 9.87E-26 | 239 |
| intracellular ribonucleoprotein complex | 2.59E-24 | 373 | 2.22E-22 | 209 | |
| ribonucleoprotein complex | 2.59E-24 | 373 | cell projection part | 1.17E-21 | 628 |
| cell body | 3.74E-23 | 348 | 8.54E-20 | 260 | |
| 2.21E-22 | 180 | 1.69E-19 | 254 | ||
| 1.61E-20 | 561 | transmembrane transporter complex | 1.69E-19 | 219 | |
| 1.88E-11 | 223 | 3.00E-22 | 891 | ||
| Metabolism of proteins | 7.40E-11 | 333 | 3.86E-21 | 216 | |
| 9.61E-10 | 162 | 1.01E-15 | 151 | ||
| Extracellular matrix organization | 4.85E-09 | 147 | 3.17E-15 | 274 | |
| Axon guidance | 9.13E-09 | 145 | Processing of Capped Intron-Containing Pre-mRNA | 2.55E-11 | 109 |
| 9.13E-09 | 117 | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | 1.95E-10 | 108 | |
| Ribosome | 1.16E-08 | 86 | 3.77E-10 | 136 | |
| 4.88E-08 | 660 | Spliceosome | 9.75E-09 | 97 | |
| 4.97E-07 | 115 | Cell Cycle, Mitotic | 3.34E-08 | 251 | |
| Collagen formation | 4.97E-07 | 59 | 4.18E-08 | 125 | |
| Ensemble of genes encoding core ECM | 5.17E-07 | 145 | mRNA Splicing | 5.81E-08 | 84 |
| Axon guidance | 8.62E-07 | 78 | mRNA Splicing—Major Pathway | 5.81E-08 | 84 |
| Biosynthesis of amino acids | 1.29E-06 | 51 | mRNA processing | 6.61E-08 | 98 |
| 2.63E-06 | 102 | TGF-beta Receptor Signaling Pathway | 9.57E-08 | 108 | |
| ECM-receptor interaction | 2.63E-06 | 57 | Carbon metabolism | 9.70E-08 | 72 |
| Translation | 2.63E-06 | 113 | 1.01E-07 | 137 | |
| Proteoglycans | 1.08E-05 | 119 | M Phase | 1.15E-07 | 151 |
| 1.08E-05 | 105 | Wnt Signaling Pathway NetPath | 1.15E-07 | 85 | |
Fig 4Bar chart representing the most significant biological functions involved in transition 1 (white bar) and transition 2 (gray bar).
The y-axis displays the negative log significance by Fisher’s Exact Test. The p-value is a measure of the likelihood that the association between a set of genes in the analyzed dataset and a related function is due to random association. The smaller the p-value, the less likely that the association is random and the more significant the association. In general, p-values < 0.05 (-log = 1.3) indicate a statistically significant, non-random association. Functions are listed from most to least significant. A -log (p-value) cutoff was set to 1.3.
Fig 5Heatmaps comparing activated canonical pathways between transition 1 (24 to 48 hpf) and transition 2 (48 to 96 hpf) based on p-value and activation z-score.
The significance p-values were calculated by Fisher's exact test right-tailed. The significance indicates the probability of association of molecules from the dataset with the canonical pathway by random chance alone. A -log (p-value) cutoff was set to 1.3. The z-score algorithm was designed to reduce the chance that random data will generate significant predictions. IPA predicts that the canonical pathway is trending towards an increase when Z-scores ≥ 1.5. Blue indicates negative z-scores. IPA predicts that the canonical pathway is trending towards a decrease when Z-scores ≤ -1.5.
Fig 6Corresponding genes to selected canonical pathways.
Closed symbols represent significantly regulated genes (FDR < 0.05) for developmental transition 1 (from 24 to 48 hpf) and open symbols for transition 2 (from 48 to 96 hpf). The Y-axis plots gene symbols and the X-axis is the log2 fold change (FC).
Fig 7Predicted mechanisms through Ingenuity Pathway Analysis showing the expression of a number of developmental genes and regulators leading to: (A) development and quantity of neurons; (B) differentiation of neurons; (C) formation of eye and increasing size of brain.